Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 52 Records) |
| Query Trace: Hepatitis A and TP53[original query] |
|---|
| XRCC1 rs25487 genetic variant and TP53 mutation at codon 249 predict clinical outcomes of hepatitis B virus-related hepatocellular carcinoma after hepatectomy: A cohort study for 10 years' follow up. Hepatology research : the official journal of the Japan Society of Hepatology 2015 Oct . Yu Long, Liu Xiaoguang, Han Chuangye, Lu Sichong, Zhu Guangzhi, Su Hao, Qi Wei, Liao Xiwen, Peng T |
| EGFR and SYNE2 are associated with p21 expression and SYNE2 variants predict post-operative clinical outcomes in HBV-related hepatocellular carcinoma. Scientific reports 2016 08 6 31237. Han Chuangye, Liao Xiwen, Qin Wei, Yu Long, Liu Xiaoguang, Chen Gang, Liu Zhengtao, Lu Sicong, Chen Zhiwei, Su Hao, Zhu Guangzhi, Lu Zili, Liu Zhiming, Qin Xue, Gui Ying, Mo Zengnan, Li Lequn, Peng T |
| ALDH1L1 variant rs2276724 and mRNA expression predict post-operative clinical outcomes and are associated with TP53 expression in HBV-related hepatocellular carcinoma. Oncology reports 2017 Jul . Zhu Guangzhi, Liao Xiwen, Han Chuangye, Liu Xiaoguang, Yu Long, Qin Wei, Lu Sicong, Su Hao, Chen Zhiwei, Liu Zhengtao, Liang Yu, Huang Jianlu, Yu Tingdong, Yang Chengkun, Huang Ketuan, Shang Liming, Ye Xinping, Li Lequn, Qin Xue, Xiao Kaiyin, Peng Minhao, Peng T |
| Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region. Hepatology (Baltimore, Md.) 2018 Aug . Li Chiao-Ling, Li Chen-Yu, Lin You-Yu, Ho Ming-Chih, Chen Ding-Shinn, Chen Pei-Jer, Yeh Shiou-Hw |
| Genome-wide association pathway analysis to identify candidate single nucleotide polymorphisms and molecular pathways associated with TP53 expression status in HBV-related hepatocellular carcinoma. Cancer management and research 2018 10 953-967. Liao Xiwen, Yu Long, Liu Xiaoguang, Han Chuangye, Yu Tingdong, Qin Wei, Yang Chengkun, Zhu Guangzhi, Su Hao, Peng T |
| Germline Duplication of SNORA18L5 Increases Risk for HBV-related Hepatocellular Carcinoma by Altering Localization of Ribosomal Proteins and Decreasing Levels of p53. Gastroenterology 2018 4 155 (2): 542-556. Cao Pengbo, Yang Aiqing, Wang Rui, Xia Xia, Zhai Yun, Li Yuanfeng, Yang Fei, Cui Ying, Xie Weimin, Liu Ying, Liu Taotao, Jia Weihua, Jiang Zhengwen, Li Zhuo, Han Yuqing, Gao Chengming, Song Qingfeng, Xie Bobo, Zhang Luo, Zhang Hongxing, Zhang Jinxu, Shen Xizhong, Yuan Yunfei, Yu Feng, Wang Ying, Xu Jing, Ma Yilong, Mo Zengnan, Yu Wuzhong, He Fuchu, Zhou Gangqi |
| Specific prognostic factors in hepatitis B virus-related and non-hepatitis B virus-related intrahepatic cholangiocarcinoma after macroscopic curative resection. Journal of surgical oncology 2019 Jan 119 (1): 40-46. Huang Jianbo, Wang Xiangyu, Zhu Ying, Wang Zheng, Li Jianhua, Xu Da, Wang Shenghao, Li Tian-En, Lu |
| Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations. Journal of hepatology 2018 1 68 (5): 959-969. Wardell Christopher P, Fujita Masashi, Yamada Toru, Simbolo Michele, Fassan Matteo, Karlic Rosa, Polak Paz, Kim Jaegil, Hatanaka Yutaka, Maejima Kazuhiro, Lawlor Rita T, Nakanishi Yoshitsugu, Mitsuhashi Tomoko, Fujimoto Akihiro, Furuta Mayuko, Ruzzenente Andrea, Conci Simone, Oosawa Ayako, Sasaki-Oku Aya, Nakano Kaoru, Tanaka Hiroko, Yamamoto Yujiro, Michiaki Kubo, Kawakami Yoshiiku, Aikata Hiroshi, Ueno Masaki, Hayami Shinya, Gotoh Kunihito, Ariizumi Shun-Ichi, Yamamoto Masakazu, Yamaue Hiroki, Chayama Kazuaki, Miyano Satoru, Getz Gad, Scarpa Aldo, Hirano Satoshi, Nakamura Toru, Nakagawa Hidewa |
| Lack of relationship between PTEN 32-bp and TP53 16-bp Ins/Del polymorphisms and chronic hepatitis B virus infection. Virusdisease 2017 Sep 28 (3): 289-294. Eskandari Ebrahim, Dahmardeh Tayebeh, Dahmardeh Fatemeh, Pahlevani Elham, Metanat Mali |
| Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma. BMC cancer 2019 8 19 (1): 789. Huang Fung-Yu, Wong Danny Ka-Ho, Tsui Vivien Wai-Man, Seto Wai-Kay, Mak Lung-Yi, Cheung Tan-To, Lai Keane K-Y, Yuen Man-Fu |
| Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 8 25 (20): 6107-6118. Kaseb Ahmed O, Sánchez Nora S, Sen Shiraj, Kelley Robin K, Tan Benjamin, Bocobo Andrea G, Lim Kian H, Abdel-Wahab Reham, Uemura Marc, Pestana Roberto Carmagnani, Qiao Wei, Xiao Lianchun, Morris Jeffrey, Amin Hesham M, Hassan Manal M, Rashid Asif, Banks Kimberly C, Lanman Richard B, Talasaz AmirAli, Mills-Shaw Kenna R, George Bhawana, Haque Abedul, Raghav Kanwal P S, Wolff Robert A, Yao James C, Meric-Bernstam Funda, Ikeda Sadakatsu, Kurzrock Razel |
| Characterization of Hepatocellular Carcinoma Patients with FGF19 Amplification Assessed by Fluorescence in situ Hybridization: A Large Cohort Study. Liver cancer 2019 3 8 (1): 12-23. Kang Hyo Jeong, Haq Farhan, Sung Chang Ohk, Choi Jene, Hong Seung-Mo, Eo Soo-Heang, Jeong Hui Jeong, Shin Jinho, Shim Ju Hyun, Lee Han Chu, An Jihyun, Kim Mi-Ju, Kim Kyu-Pyo, Ahn Sung-Min, Yu Euns |
| The diagnostic and prognostic usage of circulating tumor DNA in operable hepatocellular carcinoma. American journal of translational research 2019 11 (10): 6462-6474. An Yan, Guan Yanfang, Xu Yaping, Han Yingxin, Wu Chi, Bao Chaohui, Zhou Boping, Wang Haiyan, Zhang Mingxia, Liu Weilong, Qiu Lin, Han Zeguang, Chen Yongsheng, Xia Xuefeng, Wang Jiayin, Liu Zhentian, Huang Wanqiu, Yi Xin, Huang Ji |
| Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma. Cell 2019 10 179 (2): 561-577.e22. Gao Qiang, Zhu Hongwen, Dong Liangqing, Shi Weiwei, Chen Ran, Song Zhijian, Huang Chen, Li Junqiang, Dong Xiaowei, Zhou Yanting, Liu Qian, Ma Lijie, Wang Xiaoying, Zhou Jian, Liu Yansheng, Boja Emily, Robles Ana I, Ma Weiping, Wang Pei, Li Yize, Ding Li, Wen Bo, Zhang Bing, Rodriguez Henry, Gao Daming, Zhou Hu, Fan J |
| Analysis of TP53 aflatoxin signature mutation in hepatocellular carcinomas from Guatemala: A cross-sectional study (2016-2017). Health science reports 2020 5 3 (2): e155. Alvarez Christian S, Ortiz Jeremy, Bendfeldt-Avila Giovanna, Xie Yi, Wang Mingyi, Wu Dongjing, Higson Herbert, Lee Elisa, Teshome Kedest, Barnoya Joaquin, Kleiner David E, Groopman John D, Orozco Roberto, McGlynn Katherine A, Gharzouzi Eduardo, Dean Micha |
| Prognostic Value of?TP53?Mutation?for Transcatheter Arterial Chemoembolization?Failure/Refractoriness in HBV-Related Advanced Hepatocellular Carcinoma. Cancer research and treatment 2020 4 52 (3): 925-937. Xue Miao, Wu Yanqin, Fan Wenzhe, Guo Jian, Wei Jialiang, Wang Hongyu, Tan Jizhou, Wang Yu, Yao Wang, Zhao Yue, Li Jiapi |
| Integrative analysis of highly mutated genes in hepatitis B virus-related hepatic carcinoma. Cancer medicine 2020 2 9 (7): 2462-2479. Kong Fanyun, Kong Delong, Yang Xiaoying, Yuan Dongchen, Zhang Ning, Hua Xuan, You Hongjuan, Zheng Kuiyang, Tang Renxi |
| A Clinicopathological Study of Young-onset Hepatocellular Carcinoma. Anticancer research 2021 6 41 (6): 2933-2944. Au Kwan-Yung, Chan Kristy Kwan-Shuen, Lo Regina Cheuk-L |
| Mutation profile and its correlation with clinicopathology in Chinese hepatocellular carcinoma patients. Hepatobiliary surgery and nutrition 2021 Apr 10 (2): 172-179. Wang Shuo, Shi Huasheng, Liu Tao, Li Manjiang, Zhou Sanshun, Qiu Xuan, Wang Zusen, Hu Weiyu, Guo Weidong, Chen Xiaoqian, Guo Honglin, Shi Xiaoliang, Shi Junping, Zang Yunjin, Cao Jingyu, Wu Liq |
| Asynchronous DNA Replication of Biallelically Expressed Genes in Human Peripheral Blood Lymphocytes as a Prognostic Sign of Cancer. Sovremennye tekhnologii v meditsine 2021 10 13 (3): 33-38. Tsepenko V V, Shkavrova T G, Cherkesov V N, Golub E V, Mikhailova G |
| Deep Targeted Sequencing and Its Potential Implication for Cancer Therapy in Chinese Patients with Gastric Adenocarcinoma. The oncologist 2021 1 26 (5): e756-e768. Yu Pengfei, Wang Yusheng, Yu Yanfei, Wang Aodi, Huang Ling, Zhang Yuan, Liu Wenjing, Wu Haiyan, Yao Ming, Du Yi-An, Cheng Xiangdo |
| Genome-wide association study of the TP53 R249S mutation in hepatocellular carcinoma with aflatoxin B1 exposure and infection with hepatitis B virus. Journal of gastrointestinal oncology 2020 Dec 11 (6): 1333-1349. Han Chuangye, Yu Tingdong, Qin Wei, Liao Xiwen, Huang Jianlu, Liu Zhengtao, Yu Long, Liu Xiaoguang, Chen Zhiwei, Yang Chengkun, Wang Xiangkun, Mo Shutian, Zhu Guangzhi, Su Hao, Li Jiaquan, Qin Xue, Gui Ying, Mo Zengnan, Li Lequn, Peng T |
| Hepatocellular carcinoma after a sustained virological response by direct-acting antivirals harbors TP53 inactivation. Cancer medicine 2022 2 11 (8): 1769-1786. Imamura Taisuke, Okamura Yukiyasu, Ohshima Keiichi, Uesaka Katsuhiko, Sugiura Teiichi, Ito Takaaki, Yamamoto Yusuke, Ashida Ryo, Ohgi Katsuhisa, Otsuka Shimpei, Ohnami Sumiko, Nagashima Takeshi, Hatakeyama Keiichi, Kakuda Yuko, Sugino Takashi, Urakami Kenichi, Akiyama Yasuto, Yamaguchi K |
| Pharmacogenetic Variation and Its Clinical Relevance in a Latin American Rural Population. International journal of molecular sciences 2022 Oct 23 (19): . Olloquequi Jordi, Castro-Santos Patricia, Díaz-Peña Rober |
| CHB patients with rtA181T-mutated HBV infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes. Journal of viral hepatitis 2023 9 . Qiqi Ning, Tongwang Yang, Xianghua Guo, Yanxiang Huang, Yuxue Gao, Mengcheng Liu, Pengxiang Yang, Yuanyue Guan, Ning Liu, Yang Wang, Dexi Ch |
| Assessments of TP53 and CTNNB1 gene hotspot mutations in circulating tumour DNA of hepatitis B virus-induced hepatocellular carcinoma. Frontiers in genetics 2023 8 14 1235260. Sonu Kumar, Neeti Nadda, Afnan Quadri, Rahul Kumar, Shashi Paul, Pranay Tanwar, Shivanand Gamanagatti, Nihar Ranjan Dash, Anoop Saraya, Shalimar, Baibaswata Nay |
| Preliminary radiogenomic study of hepatitis B virus-related hepatocellular carcinoma: associations between MRI features and mutations. Personalized medicine 2023 5 . Shanshan Gao, Feihang Wang, Wei Sun, Xianling Qian, Yuan Ji, Yunfeng Cheng, Xiaolin Wang, Lingxiao Liu, Ruofan Sheng, Mengsu Ze |
| A lipid metabolism-based prognostic risk model for HBV-related hepatocellular carcinoma. Lipids in health and disease 2023 4 22 (1): 46. Zhou Lili, Xia Shaohuai, Liu Yaoyao, Ji Qiang, Li Lifeng, Gao Xuan, Guo Xiaodi, Yi Xin, Chen Fe |
| Genomic landscape of hepatocellular carcinoma in Egyptian patients by whole exome sequencing. BMC medical genomics 2024 8 17 (1): 202. Perihan Hamdy Kassem, Iman Fawzy Montasser, Ramy Mohamed Mahmoud, Rasha Ahmed Ghorab, Dina A AbdelHakam, Marium El Sayed Ahmad Fathi, Marwa A Abdel Wahed, Khaled Mohey, Mariam Ibrahim, Mohamed El Hadidi, Yasmine M Masssoud, Manar Salah, Arwa Abugable, Mohamad Bahaa, Sherif El Khamisy, Mahmoud El Metei |
| Clinicopathologic and genomic characteristics of biliary tract carcinomas with TERT promoter mutations among East Asian population. Pathology, research and practice 2025 1 266 155806. Inwoo Hwang, So Young Kang, Deok Geun Kim, Kee-Taek Jang, Kyoung-Mee K |
- Page last reviewed:Feb 1, 2024
- Content source: